Faulty prostate cancer tests
This article was originally published in The Gray Sheet
Executive SummaryU.K.'s Medicines and Healthcare products Regulatory Agency is urging men who have used Biomerica's Simplicity Health and Fortel prostate cancer home screening kits to contact their physicians after learning that some of the kits are faulty and could give false negative test results, the agency announces Nov. 4
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.